Nu Skin Enterprises (NUS) Misses Q4 EPS by 4c, provides guidance

Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $0.29, $0.04 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $370.32 million versus the consensus estimate of $392.1 million.

GUIDANCE:

Nu Skin Enterprises sees Q1 2026 EPS of $0.10-$0.20, versus the consensus of $0.27. Nu Skin Enterprises sees Q1 2026 revenue of $320-340 million, versus the consensus of $356.8 million.

Nu Skin Enterprises sees FY2026 EPS of $0.80-$1.20, versus the consensus of $1.42. Nu Skin Enterprises sees FY2026 revenue of $1.35-1.5 billion, versus the consensus of $1.53 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c